Table of Contents
- 1 What was the biggest breakthrough in cancer research?
- 2 Who is the leading cancer researcher?
- 3 What is the newest treatment for cancer?
- 4 Who discovered cancer?
- 5 Why should we research cancer?
- 6 When did the cancer epidemic start?
- 7 What’s new in cancer treatment for older adults?
- 8 Could a drug that inhibits a protein make cancer cells more vulnerable to radiation?
What was the biggest breakthrough in cancer research?
The good guys have made some major advances in the war against cancer over the past few years. One of the biggest advances involves a form of treatment known as immunotherapy.
Who is the leading cancer researcher?
Topol, Cleveland Clinic Foundation. Johns Hopkins Kimmel Cancer Center solidifies its stance as a research powerhouse in the field of Oncology with its researchers accounting for all of the top five. Bert Vogelstein, who is affiliated with Howard Hughes Medical Institute, tops the list with 27,148 citations.
What kind of scientist researches cancer?
A cancer researcher is a medical professional who uses their skills and expertise to study cancer cells, how they interact with living organisms and try to discover ways to cure or prevent the disease.
Are there any breakthroughs in cancer research?
New evidence that some cells can help cancer hide from the immune system. Dr Cathy Tournier, based at the University of Manchester, recently discovered that tumours can attract and help grow a type of cell found in our body which helps the tumour hide from the immune system.
What is the newest treatment for cancer?
Immunotherapy is a new form of cancer treatment that uses the immune system to attack cancer cells. Interventional radiology involves minimally invasive techniques using needles and catheters, and provides an alternative to surgery for some patients.
Who discovered cancer?
The disease was first called cancer by Greek physician Hippocrates (460-370 BC). He is considered the “Father of Medicine.” Hippocrates used the terms carcinos and carcinoma to describe non-ulcer forming and ulcer-forming tumors. In Greek this means a crab.
What is the strongest research design?
A well-designed randomized controlled trial, where feasible, is generally the strongest study design for evaluating an intervention’s effectiveness.
Which type of study design is the most important type of study in determining the rare side effects of a drug that occur with long term usage?
Case-control studies are particularly efficient for rare diseases because they begin by identifying a sufficient number of diseased people (or people have some “outcome” of interest) to enable you to do an analysis that tests associations.
Why should we research cancer?
Research has helped us accumulate extensive knowledge about the biological processes involved in cancer onset, growth, and spread in the body. Those discoveries have led to more effective and targeted treatments and prevention strategies.
When did the cancer epidemic start?
The world’s oldest documented case of cancer hails from ancient Egypt in 1500 BC. 2 The details were recorded on papyrus, documenting eight cases of tumors occurring on the breast.
Can a new approach bring precision cancer medicine to more patients?
A novel approach to analyzing tumors may bring precision cancer medicine to more patients. A study showed the approach, which analyzes gene expression using tumor RNA, could accurately predict whether patients had responded to treatment with targeted therapy or immunotherapy.
What are the most effective treatments for breast cancer?
A bottle of the breast cancer drug Herceptin. Until recently, chemotherapy was really the only option to treat most advanced cancers. But these drugs destroy healthy cells as well as cancerous ones, leading to toxic side effects such as nausea and a weakened immune system due to a low blood count.
What’s new in cancer treatment for older adults?
New forms of cancer treatment such as immunotherapy, for example, mean that older adults may live for many years with types of cancer traditionally considered deadly. Here’s what some of the nation’s leading cancer specialists are most excited about for the upcoming decade.
Could a drug that inhibits a protein make cancer cells more vulnerable to radiation?
The drug, which inhibits a protein called DNA polymerase theta, will be tested in NCI-supported clinical trials. A drug called avasopasem manganese, which has been found to protect normal tissues from radiation therapy, can also make cancer cells more vulnerable to radiation treatment, a new study in mice suggests.